• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病关节炎与骨关节炎和类风湿关节炎的鉴别:高级执业医师的叙述性综述与指南

Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers.

作者信息

Saalfeld William, Mixon Amanda M, Zelie Jonna, Lydon Eileen J

机构信息

Arthritis Center of Nebraska, 3901 Pine Lake Road, Suite 120, Lincoln, NE, 68516, USA.

Arthritis and Rheumatology Clinic of Northern Colorado, Fort Collins, CO, USA.

出版信息

Rheumatol Ther. 2021 Dec;8(4):1493-1517. doi: 10.1007/s40744-021-00365-1. Epub 2021 Sep 14.

DOI:10.1007/s40744-021-00365-1
PMID:34519965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8572231/
Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects multiple organ systems and is characterized by skin and joint manifestations. PsA is frequently undiagnosed and/or misdiagnosed, especially because of the similarities in clinical presentation shared with other arthritic diseases, including rheumatoid arthritis (RA) and osteoarthritis (OA). An accurate and timely diagnosis of PsA is crucial to prevent delays in optimal treatment, which can lead to irreversible joint damage and increased functional disability. Patients are usually seen by a number of different healthcare providers on their path to a diagnosis of PsA, including advanced practice providers (APPs). This review provides a comprehensive overview of the characteristic features that can be used to facilitate the differentiation of PsA from RA and OA. Detailed information on clinical manifestations, biomarkers, radiologic features, and therapeutic recommendations for PsA included here can be applied in routine clinical settings to provide APPs with the confidence and knowledge to recognize and refer patients more accurately to rheumatologists for management of patients with PsA.

摘要

银屑病关节炎(PsA)是一种影响多个器官系统的慢性炎症性疾病,其特征为皮肤和关节表现。PsA常常未被诊断和/或误诊,特别是因为它与其他关节炎疾病(包括类风湿关节炎(RA)和骨关节炎(OA))有相似的临床表现。准确及时地诊断PsA对于防止最佳治疗的延误至关重要,否则可能导致不可逆转的关节损伤和功能残疾增加。在确诊PsA的过程中,患者通常会就诊于许多不同的医疗服务提供者,包括高级执业提供者(APPs)。本综述全面概述了可用于促进PsA与RA和OA鉴别的特征。这里包含的关于PsA的临床表现、生物标志物、放射学特征和治疗建议的详细信息可应用于常规临床环境,以使APPs有信心和知识更准确地识别患者并将其转诊给风湿病学家,以便对PsA患者进行管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/21e94d660fd7/40744_2021_365_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/4bef22c87ae0/40744_2021_365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/56150b82a067/40744_2021_365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/6a3d52c4cbfb/40744_2021_365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/c7c13f8d1948/40744_2021_365_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/21e94d660fd7/40744_2021_365_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/4bef22c87ae0/40744_2021_365_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/56150b82a067/40744_2021_365_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/6a3d52c4cbfb/40744_2021_365_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/c7c13f8d1948/40744_2021_365_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7be8/8572231/21e94d660fd7/40744_2021_365_Fig5_HTML.jpg

相似文献

1
Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers.银屑病关节炎与骨关节炎和类风湿关节炎的鉴别:高级执业医师的叙述性综述与指南
Rheumatol Ther. 2021 Dec;8(4):1493-1517. doi: 10.1007/s40744-021-00365-1. Epub 2021 Sep 14.
2
Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists.远程医疗与银屑病关节炎:皮肤科医生和风湿病医生的最佳实践和注意事项。
Clin Rheumatol. 2022 May;41(5):1271-1283. doi: 10.1007/s10067-022-06077-3. Epub 2022 Jan 26.
3
Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.银屑病关节炎的临床特征:未满足的临床需求的综合综述。
Clin Rev Allergy Immunol. 2018 Dec;55(3):271-294. doi: 10.1007/s12016-017-8630-7.
4
Characterisation of hand small joints arthropathy using high-resolution MRI--limited discrimination between osteoarthritis and psoriatic arthritis.采用高分辨率 MRI 对手小关节关节炎进行特征分析--对骨关节炎和银屑病关节炎的鉴别能力有限。
Eur Radiol. 2013 Jun;23(6):1686-93. doi: 10.1007/s00330-012-2739-0. Epub 2013 Jan 9.
5
Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study.循环 Mir-140 和瘦素可提高银屑病关节炎和类风湿关节炎鉴别诊断的准确性:一项病例对照研究。
Transl Res. 2022 Jan;239:18-34. doi: 10.1016/j.trsl.2021.08.001. Epub 2021 Aug 8.
6
Synovial Fluid and Serum Concentrations of Inflammatory Markers in Rheumatoid Arthritis, Psoriatic Arthritis and Osteoarthitis: A Systematic Review.类风湿关节炎、银屑病关节炎和骨关节炎中炎症标志物的滑液和血清浓度:一项系统评价
Curr Rheumatol Rev. 2017;13(3):170-179. doi: 10.2174/1573397113666170427125918.
7
Introduction of a metabolic joint asymmetry score derived from conventional bone scintigraphy. A new tool to differentiate psoriatic from rheumatoid arthritis.介绍一种源自传统骨闪烁显像的代谢关节不对称评分。一种区分银屑病关节炎和类风湿关节炎的新工具。
Nuklearmedizin. 2015;54(4):183-9. doi: 10.3413/Nukmed-0698-14-09. Epub 2015 Apr 13.
8
Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.类风湿关节炎、银屑病关节炎和骨关节炎中抗环瓜氨酸肽抗体和 IgA 类风湿因子的滑液水平。
Arthritis Rheum. 2006 Feb 15;55(1):53-6. doi: 10.1002/art.21691.
9
Radiographic scoring methods in rheumatoid arthritis and psoriatic arthritis.类风湿关节炎和银屑病关节炎的放射学评分方法。
Radiol Med. 2019 Nov;124(11):1071-1086. doi: 10.1007/s11547-019-01001-3. Epub 2019 Feb 9.
10
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis.银屑病关节炎与类风湿因子/抗瓜氨酸抗体阴性类风湿关节炎患者的滑膜组织生物标志物的差异。
Arthritis Res Ther. 2019 May 9;21(1):116. doi: 10.1186/s13075-019-1898-7.

引用本文的文献

1
Investigation of serum biomarkers in rheumatoid and psoriatic arthritis patients for disease-specific signatures.类风湿性关节炎和银屑病关节炎患者血清生物标志物的疾病特异性特征研究。
Arthritis Res Ther. 2025 Jul 10;27(1):147. doi: 10.1186/s13075-025-03608-6.
2
Medical Ozone Increases Methotrexate Effects in Rheumatoid Arthritis Through a Shared New Mechanism Which Involves Adenosine.医用臭氧通过一种涉及腺苷的共同新机制增强甲氨蝶呤在类风湿性关节炎中的疗效。
Int J Mol Sci. 2025 May 29;26(11):5256. doi: 10.3390/ijms26115256.
3
A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 Weeks.

本文引用的文献

1
Axial Psoriatic Arthritis.轴向银屑病关节炎。
Curr Rheumatol Rep. 2021 Apr 28;23(6):35. doi: 10.1007/s11926-021-00999-8.
2
Nail Psoriasis: Diagnosis, Assessment, Treatment Options, and Unmet Clinical Needs.甲银屑病:诊断、评估、治疗选择和未满足的临床需求。
J Rheumatol. 2021 Aug;48(8):1208-1220. doi: 10.3899/jrheum.201471. Epub 2021 Feb 15.
3
Axial psoriatic arthritis: An update for dermatologists.轴向银屑病关节炎:皮肤科医生的最新进展。
在52周内对银屑病关节炎患者进行的古塞库单抗与司库奇尤单抗的匹配调整间接比较。
Rheumatol Ther. 2025 Jun 1. doi: 10.1007/s40744-025-00771-9.
4
Real-World Utilization of Biologic and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs in Psoriatic Arthritis and Axial Spondyloarthritis: Insights from Sweden and Germany.生物制剂和靶向合成改善病情抗风湿药物在银屑病关节炎和中轴型脊柱关节炎中的真实世界应用:来自瑞典和德国的见解
Adv Ther. 2025 May 22. doi: 10.1007/s12325-025-03216-5.
5
Challenging the Dogma That Psoriasis Skin Lesions Occur Before Arthritis.挑战银屑病皮肤病变先于关节炎出现的教条。
Int J Dermatol. 2025 Sep;64(9):1632-1635. doi: 10.1111/ijd.17862. Epub 2025 May 21.
6
Biomarkers in Psoriasis: The Future of Personalised Treatment.银屑病中的生物标志物:个性化治疗的未来。
Indian J Dermatol. 2024 May-Jun;69(3):256-263. doi: 10.4103/ijd.ijd_167_24. Epub 2024 Jun 26.
7
Psoriatic arthritis with psychological comorbidities: an overview of systematic reviews on incidence, prevalence, and geographic disparities.伴心理共病的银屑病关节炎:系统综述对发病率、患病率和地理差异的概述。
Rheumatol Int. 2024 Nov;44(11):2337-2355. doi: 10.1007/s00296-024-05617-1. Epub 2024 May 26.
8
Medical Ozone: A Redox Regulator with Selectivity for Rheumatoid Arthritis Patients.医用臭氧:一种对类风湿关节炎患者具有选择性的氧化还原调节剂。
Pharmaceuticals (Basel). 2024 Mar 19;17(3):391. doi: 10.3390/ph17030391.
9
Probing the antinociceptive and therapeutic potential of probiotics in managing temporomandibular joint arthritis.探究益生菌在治疗颞下颌关节关节炎中的抗伤害感受及治疗潜力。
J Taibah Univ Med Sci. 2024 Feb 3;19(2):372-378. doi: 10.1016/j.jtumed.2024.01.004. eCollection 2024 Apr.
10
Comprehensive analysis of mitochondrial DNA variants, mitochondrial DNA copy number and oxidative damage in psoriatic arthritis.银屑病关节炎中线粒体DNA变异、线粒体DNA拷贝数及氧化损伤的综合分析
Biomed Rep. 2023 Sep 26;19(5):85. doi: 10.3892/br.2023.1667. eCollection 2023 Nov.
J Am Acad Dermatol. 2021 Jan;84(1):92-101. doi: 10.1016/j.jaad.2020.05.089. Epub 2020 Jul 31.
4
Prevalence of sacroiliitis and acute and structural changes on MRI in patients with psoriatic arthritis.银屑病关节炎患者的骶髂关节炎及 MRI 上的急性和结构变化的患病率。
Sci Rep. 2020 Jul 14;10(1):11580. doi: 10.1038/s41598-020-68456-7.
5
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.EULAR 推荐的药物治疗银屑病关节炎管理:2019 年更新。
Ann Rheum Dis. 2020 Jun;79(6):700-712. doi: 10.1136/annrheumdis-2020-217159.
6
Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.司库奇尤单抗治疗活动性银屑病关节炎(EXCEED):一项双盲、平行组、随机、主动对照、3b 期临床试验。
Lancet. 2020 May 9;395(10235):1496-1505. doi: 10.1016/S0140-6736(20)30564-X.
7
Axial Psoriatic Arthritis: A Distinct Clinical Entity in Search of a Definition.轴性银屑病关节炎:一种寻求定义的独特临床实体。
Rheum Dis Clin North Am. 2020 May;46(2):327-341. doi: 10.1016/j.rdc.2020.01.009.
8
Regulatory T cells in patients with early untreated rheumatoid arthritis: Phenotypic changes in the course of methotrexate treatment.早期未经治疗的类风湿关节炎患者中的调节性 T 细胞:甲氨蝶呤治疗过程中的表型变化。
Biochimie. 2020 Jul;174:9-17. doi: 10.1016/j.biochi.2020.03.014. Epub 2020 Apr 7.
9
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. Guselkumab 在生物制剂初治的活动性银屑病关节炎患者中的疗效(DISCOVER-2):一项双盲、随机、安慰剂对照的 3 期临床试验。
Lancet. 2020 Apr 4;395(10230):1126-1136. doi: 10.1016/S0140-6736(20)30263-4. Epub 2020 Mar 13.
10
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.古塞单抗治疗生物制剂初治或既往接受 TNFα 抑制剂治疗的活动性银屑病关节炎患者(DISCOVER-1):一项双盲、随机、安慰剂对照的 3 期临床试验。
Lancet. 2020 Apr 4;395(10230):1115-1125. doi: 10.1016/S0140-6736(20)30265-8. Epub 2020 Mar 13.